Neuroscience Chemistry, Pfizer Global Research and Development, Groton, CT 06340, USA.
J Med Chem. 2009 Dec 24;52(24):7946-9. doi: 10.1021/jm9015334.
By use of chemical enablement and prospective design, a novel series of selective, brain penetrant PDE9A inhibitors have been identified that are capable of producing in vivo elevations of brain cGMP.
通过化学激活和前瞻性设计,我们鉴定了一系列新型的、可穿透血脑屏障的选择性 PDE9A 抑制剂,这些抑制剂能够在体内引起脑 cGMP 的升高。